In this first partnership for the dental solutions, soluble, former 3 m. Sanitary care is trying to focus on the longevity and durability of the same day’s permanent rehabilitation dental offers, confirming its commitment to resolve the most difficult problems in the industry
The partnership aims to integrate innovative new science of materials and disturbed technology such as printing 3D of origin to optimize work flows, enhancing procedural efficiency and benefit both patients and professionals
St. Paul, minn.; March 25 2025 / Prnewswire/ – Solver (Nyse: Solv), the leader in dental composite and rehabilitation dentistry, announced a strategic partnership with Sprintray, a leading chair of dental printing 3D, to meet the needs of dentists with printed crowns, 3D prints, integrals and many more. This research and development (R&D) and the commercialization agreement focuses on the development and achievement of the market for high quality, durable and permanent rehabilitation of the same day-with patients and dentists to expect current laboratory processes.
Dental solvent solutions link leadership materials to data science to help dentists solve their most difficult challenges with products such as Filtek ™ Easy Match Universal Restorative, Filtek ™ Matrix, Scotchbond ™ Universal and Relyx ™ Universal Cement. Sprintray offers innovative President Ecosystems 3D of end to end, which create a platform for a wide range of dental applications.
With the legacy of the soluble material science with top Sprintray’s top -notch materials and innovative technology, the collaboration aims to bring the first permanent chair, 3D Printed Crown. Together, the solvent and Sprintray predict the improvement of the experience and results of patients through fewer office visits – effectiveness of practical driving and ultimately providing the results of the results and providers.
“Imagine a world where your dentist can create a crown that can take decades in a few minutes,” he said Karim MansourPresident, dental solutions, soluble. “We believe that this collaboration will revolutionize the way dentists and orthodontists take care of patients with production in the office, offering a simplified process that we expect to improve results and experiences, reduce chair time and lower treatment costs.
The offer of 3D printing technology directly to dentists and orthodontists will streamline the care of patients and providers, allowing dental group to be provided and introduced a purchase of permanent 3D printed crowns, investments, onlays and others.
“Together, we can have a significant impact on restorative dentistry with the building of excellent products to treat the same visits,” Sprintray’s CEO said. Amir Mansouri. “Our collaboration with Solventum is a basic cooperation and commitment to make the difference in people’s oral health, as well as the provision of high quality and cost -effective dental restorations around the world.”
The announcement of the partnership is aligned with the soluble soluble inheritance for quality science of materials and is an example of bias resources to development, while enhancing the digital potential, two elements of the previously released soluble plan. As the winner of the seven Dental Advisor Awards in 2024, the partnership follows four new imports of products launched in 2024, including:
Solventum will share more details on the strategic collaboration on the International Dental Show (IDS) 2025 March 26 in Cologne, Germany.
For the solvent
In the solvent, we allow the best, smarter, safer health care to improve life. As a new company with a long legacy of solutions for the most difficult challenges of our customers, we are pioneering in innovations that change the game at the intersection of health, materials and science that changes the lives of patients for the better-in force their healthcare professionals. See how in Solventum.com.
Future Fulfillments
This press release contains information on the financial results, estimates and business perspectives of the soluble that include significant risks and uncertainties. Specifically, statements regarding future solvent performance, including guidance for 2024, are forward statements. You can identify these statements using words such as “expect”, “believes”, “could”, “estimates”, “awaits”, “goals”, “guidance”, or financial performance or business plans or perspectives. Among the factors that could cause the actual results: International, commercial and geopolitical conditions, natural disasters, war, public health crises and other events beyond the control of soluble; (2) dangers of operational execution; (3) damage to our reputation or brands. Healthcare Branch. (9) Changes in the return practices of governments or private payers or other cost retention measures; (10) The soluble’s ability to receive components or raw materials provided by third parties and other construction difficulties and relative difficulties of the supply chain, interruptions and disturbed factors; (11). failure of the soluble to obtain, maintain, protect or effectively enforce intellectual property rights (“IP”).
Changes in such cases or factors could produce significant different results. A further description of these factors is in the “warning note on future fulfillment statements” and “risk factors” in Solventum’s periodic reports in the US Securities and Exchange Commission. Solventum does not undertake any obligation to inform statements referred to in the future as a result of new information or future events or developments.
Source
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish
Turkish